BDBM135436 US8846657, 18.4

SMILES: C[C@H]1CC[C@H](Cn2c(nc3cc(nc(-c4cc(Cl)cnc4OCCO)c23)-c2noc(=O)[nH]2)N2CCO[C@@H]3CCC[C@@H]23)CC1

InChI Key:

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 135436   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
MDM2-MDMX (Homo sapiens (Human))	BDBM135436 (US8846657, 18.4) Show SMILES C[C@H]1CC[C@H](Cn2c(nc3cc(nc(-c4cc(Cl)cnc4OCCO)c23)-c2noc(=O)[nH]2)N2CCO[C@@H]3CCC[C@@H]23)CC1 |r,wU:36.40,4.4,wD:40.43,1.0,(7.31,-5.23,;5.97,-4.46,;5.97,-2.92,;4.64,-2.15,;3.3,-2.92,;1.97,-2.15,;1.97,-.61,;2.88,.64,;1.97,1.88,;.51,1.41,;-.83,2.18,;-2.16,1.41,;-2.16,-.13,;-.83,-.9,;-.83,-2.44,;.51,-3.21,;.51,-4.75,;1.84,-5.52,;-.83,-5.52,;-2.16,-4.75,;-2.16,-3.21,;-3.49,-2.44,;-4.83,-3.21,;-6.16,-2.44,;-7.5,-3.21,;.51,-.13,;-3.49,2.18,;-4.96,1.7,;-5.86,2.95,;-4.96,4.19,;-5.73,5.52,;-3.49,3.72,;4.42,.64,;5.19,-.7,;6.73,-.7,;7.5,.64,;6.73,1.97,;7.2,3.43,;5.96,4.34,;4.71,3.43,;5.19,1.97,;3.3,-4.46,;4.64,-5.23,)| Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...				US Patent US8962611 (2015) BindingDB Entry DOI: 10.7270/Q28G8JDZ
					More data for this Ligand-Target Pair
MDM2-MDMX (Homo sapiens (Human))	BDBM135436 (US8846657, 18.4) Show SMILES C[C@H]1CC[C@H](Cn2c(nc3cc(nc(-c4cc(Cl)cnc4OCCO)c23)-c2noc(=O)[nH]2)N2CCO[C@@H]3CCC[C@@H]23)CC1 |r,wU:36.40,4.4,wD:40.43,1.0,(7.31,-5.23,;5.97,-4.46,;5.97,-2.92,;4.64,-2.15,;3.3,-2.92,;1.97,-2.15,;1.97,-.61,;2.88,.64,;1.97,1.88,;.51,1.41,;-.83,2.18,;-2.16,1.41,;-2.16,-.13,;-.83,-.9,;-.83,-2.44,;.51,-3.21,;.51,-4.75,;1.84,-5.52,;-.83,-5.52,;-2.16,-4.75,;-2.16,-3.21,;-3.49,-2.44,;-4.83,-3.21,;-6.16,-2.44,;-7.5,-3.21,;.51,-.13,;-3.49,2.18,;-4.96,1.7,;-5.86,2.95,;-4.96,4.19,;-5.73,5.52,;-3.49,3.72,;4.42,.64,;5.19,-.7,;6.73,-.7,;7.5,.64,;6.73,1.97,;7.2,3.43,;5.96,4.34,;4.71,3.43,;5.19,1.97,;3.3,-4.46,;4.64,-5.23,)| Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Merck Sharp & Dohme Corp. US Patent					Assay Description Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...				US Patent US8846657 (2014) BindingDB Entry DOI: 10.7270/Q29C6W3K
					More data for this Ligand-Target Pair